Back to Search Start Over

Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity.

Authors :
Crouch, Eric R.
Kraker, Raymond T.
Wallace, David K.
Holmes, Jonathan M.
Repka, Michael X.
Collinge, Janine E.
Bremer, Don L.
Gray, Michael E.
Smith, Heather A.
Steinkuller, Paul G.
Writing Committee for the Pediatric Eye Disease Investigator Group
Writing Committee for Pediatric Eye Disease Investigator Group
Source :
JAMA Ophthalmology; Jan2020, Vol. 138 Issue 1, p14-20, 7p
Publication Year :
2020

Details

Language :
English
ISSN :
21686165
Volume :
138
Issue :
1
Database :
Complementary Index
Journal :
JAMA Ophthalmology
Publication Type :
Academic Journal
Accession number :
141155441
Full Text :
https://doi.org/10.1001/jamaophthalmol.2019.4488
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details